Whether changes at the ERV1-3 locus in glial cells of MS patients reflect the physiological role of HERV-R (per se or via regulation of neighbouring genes) as reported [89] or rather a pathogenic event, as described for other HERVs remain to be ascertained. This evidence concerns the gene ERV3-1 and myeloid sarcoma.